Cyteir Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass., Jan. 7, 2021 /PRNewswire/ -- Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal therapies to treat cancer, today announced that Markus Renschler, M.D., Cyteir's president and chief executive officer, will present a scientific and business update at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:30 p.m. Eastern Time. A Q&A breakout session will immediately follow the presentation at 5:45 p.m. Eastern Time.
About Cyteir Therapeutics
© 2021 Cyteir Therapeutics, Inc. All rights reserved. Cyteir Therapeutics, Cyteir, and associated logos are trademarks of Cyteir Therapeutics, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cyteir-therapeutics-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301202568.html
SOURCE Cyteir Therapeutics